MedTrace Logo

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

NCT04804969 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 575

Last updated 2023-09-21

No results posted yet for this study

Summary

Clinical validation study of the MyoVista wavECG.

Conditions

  • Cardiac Disease

Interventions

DEVICE

MyoVista wavECG Test

The MyoVista wavECG is a standard 12-Lead high-performance, multi-channel resting interpretive electrocardiograph providing both a Glasgow Interpretive Analysis and unique MyoVista wavECG Information.

Sponsors & Collaborators

  • Heart Test Laboratories, Inc.

    lead INDUSTRY

Principal Investigators

  • Partho Sengupta, MD · Robert Wood Johnson University Hospital

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-10
Primary Completion
2023-11-30
Completion
2023-11-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04804969 on ClinicalTrials.gov